Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2013

01-01-2013 | Original Research

The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey—Two Centers Study

Authors: Sara S. Kilic, Mustafa Ozel, Demet Hafizoglu, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer

Published in: Journal of Clinical Immunology | Issue 1/2013

Login to get access

Abstract

Purpose

Primary immunodeficiency diseases (PIDs) are inherited disorders of the immune system resulting in increased susceptibility to unusual infections and predisposition to autoimmunity and malignancies. The European Society for Immunodeficiencies (ESID) has developed an internet-based database for clinical and research data on patients with PID. This study aimed to provide a minimum estimate of the prevalence of each disorder and to determine the clinical characteristics and outcomes of patients with PID in Turkey.

Methods

Clinical features of 1435 patients with primary immunodeficiency disorders are registered in ESID Online Patient Registry by the Pediatric Immunology Departments of the Medical Faculties of Uludag University and Ege University Between 2004 and 2010. These two centers are the major contributors reporting PID patients to ESID database from Turkey.

Results

Predominantly antibody immunodeficiency (73.5 %) was the most common category followed by autoinflammatory disorders (13.3 %), other well defined immunodeficiencies (5.5 %), congenital defects of phagocyte number, function or both 3.5 %), combined T and B cell immunodeficiencies (2 %), defects in innate immunity (1 %), and diseases of immune dysregulation (0.7 %). Patients between 0 and 18 years of age constitued 94 % of total and the mean age was 9.2 ± 6 years. The consanguinity rate within the registered patients was 14.3 % (188 of 1130 patients). The prevalance of all PID cases ascertained from the registry was 30.5/100.000. The major cause of the mortality was severe infection which was seen in forty-two of seventy five deceased patients. The highest mortality was observed in patients with severe combined immunodeficiencies and ataxia-telangiectasia.

Conclusion

Promoting the awareness of PID among the medical professionals and the general public is required if premature death and serious morbidity occurs due to late diagnosis of the wider spectrum of PID are to be avoided.
Literature
1.
go back to reference Samarghitean C, Väliaho J, Vihinen M. IDR knowledge base for primary immunodeficiencies. Immunome Res. 2007;3:6.PubMedCrossRef Samarghitean C, Väliaho J, Vihinen M. IDR knowledge base for primary immunodeficiencies. Immunome Res. 2007;3:6.PubMedCrossRef
2.
go back to reference Guzman D, Veit D, Knerr V, Kindle G, Gathmann B, Eades-Perner AM. The ESID Online Database network. Bioinformatics. 2007;23:654–55.PubMedCrossRef Guzman D, Veit D, Knerr V, Kindle G, Gathmann B, Eades-Perner AM. The ESID Online Database network. Bioinformatics. 2007;23:654–55.PubMedCrossRef
3.
go back to reference Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol. 2007;7:851–61.PubMedCrossRef Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol. 2007;7:851–61.PubMedCrossRef
4.
go back to reference Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.PubMedCrossRef Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.PubMedCrossRef
5.
go back to reference Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997;100:415–23.PubMedCrossRef Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997;100:415–23.PubMedCrossRef
6.
go back to reference Golan H, Dalal I, Garty B, Schlesinger M, Levy J, Handzel Z, et al. The incidence of primary immunodeficiency syndromes in Israel. IMAJ. 2002;4(Suppl):S868–71. Golan H, Dalal I, Garty B, Schlesinger M, Levy J, Handzel Z, et al. The incidence of primary immunodeficiency syndromes in Israel. IMAJ. 2002;4(Suppl):S868–71.
7.
go back to reference Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol. 2006;26:519–32.PubMedCrossRef Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol. 2006;26:519–32.PubMedCrossRef
8.
go back to reference Al-Herz W. Primary immunodeficiency disorders in Kuwait: First report from Kuwait national primary immunodeficiency registry. J Clin Immunol. 2008;28:186–93.PubMedCrossRef Al-Herz W. Primary immunodeficiency disorders in Kuwait: First report from Kuwait national primary immunodeficiency registry. J Clin Immunol. 2008;28:186–93.PubMedCrossRef
9.
go back to reference Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.PubMedCrossRef Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.PubMedCrossRef
10.
go back to reference Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27:510–6.PubMedCrossRef Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27:510–6.PubMedCrossRef
11.
go back to reference Stray-Pedersen A, Abrahamsen T, Froland S. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20:477–85.PubMedCrossRef Stray-Pedersen A, Abrahamsen T, Froland S. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20:477–85.PubMedCrossRef
12.
go back to reference Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan Casariego G. Primary immunodeficiency syndrome in Spain: First report of the national registry in children and adults. J Clin Immunol. 1997;17:333–9.PubMedCrossRef Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan Casariego G. Primary immunodeficiency syndrome in Spain: First report of the national registry in children and adults. J Clin Immunol. 1997;17:333–9.PubMedCrossRef
13.
go back to reference Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: A single-center study. J Clin Immunol. 2009;29:343–51.PubMedCrossRef Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: A single-center study. J Clin Immunol. 2009;29:343–51.PubMedCrossRef
14.
go back to reference Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497–502.PubMedCrossRef Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497–502.PubMedCrossRef
15.
go back to reference Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157(1):3–11.PubMedCrossRef Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157(1):3–11.PubMedCrossRef
18.
go back to reference CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264–72.CrossRef CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264–72.CrossRef
19.
go back to reference Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: First report of the national registry in children and adults. J Clin Immunol. 2005;25:73–7.PubMedCrossRef Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: First report of the national registry in children and adults. J Clin Immunol. 2005;25:73–7.PubMedCrossRef
20.
go back to reference Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)–diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.PubMedCrossRef Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)–diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.PubMedCrossRef
21.
go back to reference Report of a WHO scientific group. Primary immunodeficiency diseases. Clin Exp Immunol. 1997;109(1):1–28.CrossRef Report of a WHO scientific group. Primary immunodeficiency diseases. Clin Exp Immunol. 1997;109(1):1–28.CrossRef
22.
go back to reference Savic S, Dickie LJ, Battellino M, McDermott MF. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol. 2012;24:103–12.PubMedCrossRef Savic S, Dickie LJ, Battellino M, McDermott MF. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol. 2012;24:103–12.PubMedCrossRef
23.
go back to reference Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley BS. Primary immunodeficiencies: A 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J Clin Immunol. 2011;31:99–105.PubMedCrossRef Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley BS. Primary immunodeficiencies: A 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J Clin Immunol. 2011;31:99–105.PubMedCrossRef
24.
go back to reference Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol. 2009;29:357–64.PubMedCrossRef Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol. 2009;29:357–64.PubMedCrossRef
Metadata
Title
The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey—Two Centers Study
Authors
Sara S. Kilic
Mustafa Ozel
Demet Hafizoglu
Neslihan Edeer Karaca
Guzide Aksu
Necil Kutukculer
Publication date
01-01-2013
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2013
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-012-9763-3

Other articles of this Issue 1/2013

Journal of Clinical Immunology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine